SLSong Li

Song Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Song Li has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Hong Sha

    Institute of Biomedical Engineering, Chinese Academy of Medical Sciences, Tianjin 300192, China

    1 shared publication
  • Hong Wang

    Institute of Biomedical Engineering, China Academy of Medical Science & Peking Union Medical College, Tianjin, China

    1 shared publication
  • Qiang Liu

    Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

    1 shared publication
  • Wenjun Tu

    Institute of Radiation Medicine, China Academy of Medical Science & Peking Union Medical College, Tianjin, China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases

    by Wenjun Tu, Hong Wang, Song Li, Qiang Liu, Hong Sha

    Oxidative stress is defined as an imbalance between production of free radicals and reactive metabolites or [reactive oxygen species (ROS)] and their elimination by through protective mechanisms, including (antioxidants). This Such imbalance leads to damage of cells and important biomolecules and cells, with hence posing a potential adverse impact on the whole organism. At the center of the day-to-day biological response to oxidative stress is the Kelch-like ECH-associated protein 1 (Keap1) - nuclear factor erythroid 2-related factor 2 (Nrf2)- antioxidant response elements (ARE) pathway, which regulates the transcription of many several antioxidant genes that preserve cellular homeostasis and detoxification genes that process and eliminate carcinogens and toxins before they can cause damage. The redox-sensitive signaling system Keap1/Nrf2/ARE plays a key role in the maintenance of cellular homeostasis under stress, inflammatory, carcinogenic, and pro-apoptotic conditions, which allows us to consider it as a pharmacological target. Herein, we review and discuss the recent advancements in the regulation of the Keap1/Nrf2/ARE system, and its role under physiological and pathophysiological conditions, e.g. such as in exercise, diabetes, cardiovascular diseases, cancer, neurodegenerative disorders, stroke, liver and kidney system, etc. and such.